Prescribing errors in hospitalized patients on the ketogenic diet.

IF 2.3 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Cheng Yu Yen, Lauren Kronisch, Kayleen Whitley, Byronae Carew, Arturo Zaldana, Gloria Diaz-Medina, Akshat Katyayan, Jon A Cokley
{"title":"Prescribing errors in hospitalized patients on the ketogenic diet.","authors":"Cheng Yu Yen, Lauren Kronisch, Kayleen Whitley, Byronae Carew, Arturo Zaldana, Gloria Diaz-Medina, Akshat Katyayan, Jon A Cokley","doi":"10.1093/ajhp/zxaf036","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>A ketogenic diet (KD) is recommended as a nonpharmacological treatment option in pediatric patients with epilepsy. Prescribing errors for these patients can result in inadvertent carbohydrate exposure, increasing the risk of loss of ketosis and breakthrough seizures. The objective of this study was to evaluate the incidence of inadvertent carbohydrate exposure in hospitalized children on the traditional KD.</p><p><strong>Methods: </strong>This was a retrospective cohort study of patients with epilepsy receiving KD therapy while admitted to the hospital. Patients 18 years of age or younger diagnosed with epilepsy and/or intractable epilepsy, receiving antiseizure medications on the traditional KD or KD total parenteral nutrition, or with GLUT-1 genetic disorder were included. The primary endpoint was the incidence of patient admissions with unintended orders for carbohydrate-containing medications during hospitalization.</p><p><strong>Results: </strong>A total of 42 patients accounting for 66 inpatient admissions were included in this study. The total incidence of admissions with an inadvertent carbohydrate-containing medication order placed was 52% for intravenous (IV) medications and 64% for oral medications. Patients averaged 2 carbohydrate-containing orders per admission for both IV and oral medications. The most commonly prescribed carbohydrate-containing medications were given at least once before being discontinued. Of the IV medications documented in this study, 6 were premix products diluted in carbohydrate-containing solutions and did not have an alternative file built to facilitate dilution in normal saline.</p><p><strong>Conclusion: </strong>Because of their restricted carbohydrate allowance and the possibility of carbohydrate-containing product excipients, patients on the KD are at increased risk for receiving inappropriate carbohydrate-containing medications during hospital admissions.</p>","PeriodicalId":7577,"journal":{"name":"American Journal of Health-System Pharmacy","volume":" ","pages":"S2937-S2942"},"PeriodicalIF":2.3000,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Health-System Pharmacy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ajhp/zxaf036","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: A ketogenic diet (KD) is recommended as a nonpharmacological treatment option in pediatric patients with epilepsy. Prescribing errors for these patients can result in inadvertent carbohydrate exposure, increasing the risk of loss of ketosis and breakthrough seizures. The objective of this study was to evaluate the incidence of inadvertent carbohydrate exposure in hospitalized children on the traditional KD.

Methods: This was a retrospective cohort study of patients with epilepsy receiving KD therapy while admitted to the hospital. Patients 18 years of age or younger diagnosed with epilepsy and/or intractable epilepsy, receiving antiseizure medications on the traditional KD or KD total parenteral nutrition, or with GLUT-1 genetic disorder were included. The primary endpoint was the incidence of patient admissions with unintended orders for carbohydrate-containing medications during hospitalization.

Results: A total of 42 patients accounting for 66 inpatient admissions were included in this study. The total incidence of admissions with an inadvertent carbohydrate-containing medication order placed was 52% for intravenous (IV) medications and 64% for oral medications. Patients averaged 2 carbohydrate-containing orders per admission for both IV and oral medications. The most commonly prescribed carbohydrate-containing medications were given at least once before being discontinued. Of the IV medications documented in this study, 6 were premix products diluted in carbohydrate-containing solutions and did not have an alternative file built to facilitate dilution in normal saline.

Conclusion: Because of their restricted carbohydrate allowance and the possibility of carbohydrate-containing product excipients, patients on the KD are at increased risk for receiving inappropriate carbohydrate-containing medications during hospital admissions.

生酮饮食住院患者的处方错误。
免责声明:为了加快文章的发表,AJHP在接受稿件后将尽快在网上发布。被接受的稿件已经过同行评审和编辑,但在技术格式化和作者校对之前会在网上发布。这些手稿不是记录的最终版本,稍后将被最终文章(按照AJHP风格格式化并由作者校对)所取代。目的:生酮饮食(KD)被推荐为儿童癫痫患者癫痫发作管理的非药物治疗选择。然而,医院对这些患者的处方错误可能导致无意中给药碳水化合物,并可能增加失去酮症和突破性癫痫发作的风险。本研究的目的是评估住院儿童在传统KD治疗中误服含碳水化合物药物的发生率。方法:本研究是对住院时接受KD治疗的儿童癫痫患者进行回顾性队列研究。被诊断为癫痫和/或顽固性癫痫的18岁或以下患者,入院时接受传统KD或KD全肠外营养抗癫痫药物,或伴有GLUT-1遗传疾病的患者被纳入研究。主要终点是住院期间意外订购含碳水化合物药物的患者入院发生率。结果:本研究共纳入66例住院患者42例。静脉注射(IV)药物和口服药物的总发生率分别为52%和64%。患者每次入院平均服用2个含碳水化合物的单次静脉和口服药物。最常用的含碳水化合物药物在停药前至少服用一次。在本研究中记录的静脉注射药物中,有6种是在含碳水化合物的溶液中稀释的预混产品,没有建立替代文件以促进在生理盐水中稀释。结论:由于受限制的碳水化合物用量和含碳水化合物产品辅料的可能性,KD患者在住院期间接受不适当的含碳水化合物药物的风险增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.90
自引率
18.50%
发文量
341
审稿时长
3-8 weeks
期刊介绍: The American Journal of Health-System Pharmacy (AJHP) is the official publication of the American Society of Health-System Pharmacists (ASHP). It publishes peer-reviewed scientific papers on contemporary drug therapy and pharmacy practice innovations in hospitals and health systems. With a circulation of more than 43,000, AJHP is the most widely recognized and respected clinical pharmacy journal in the world.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信